Order Article Reprints

Wieringa A, Ewoldt TMJ, Gangapersad RN, Gijsen M, Parolya N, Kats CJAR, Spriet I, Endeman H, Haringman JJ, van Hest RM, et al. Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics. 2023; 12(12):1674. https://doi.org/10.3390/antibiotics12121674

Wieringa, André, Tim M. J. Ewoldt, Ravish N. Gangapersad, Matthias Gijsen, Nestor Parolya, Chantal J. A. R. Kats, Isabel Spriet, Henrik Endeman, Jasper J. Haringman, Reinier M. van Hest, and et al. 2023. "Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models" Antibiotics 12, no. 12: 1674. https://doi.org/10.3390/antibiotics12121674

Wieringa, A., Ewoldt, T. M. J., Gangapersad, R. N., Gijsen, M., Parolya, N., Kats, C. J. A. R., Spriet, I., Endeman, H., Haringman, J. J., van Hest, R. M., Koch, B. C. P., & Abdulla, A., on behalf of the DOLPHIN Investigators. (2023). Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics, 12(12), 1674. https://doi.org/10.3390/antibiotics12121674